Maria E. Martinez is Director at Mirati Therapeutics, Inc. (MRTX). They have made 1 open-market trade across 1 company since 2021, most recently 2024-01-23.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRTX | 11,252 | $660K |
Shares reported on the most recent Form 4, priced at the 2024-01-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRTX | SELL | 2021-01-29 | 2021-02-01 | $203.35 | $2.7M | +8.7% | -2.8% | -16.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.